Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Precision Health Database


Genomics & Health Impact Scan Database|Search|PHGKB

Cancer

Last data update: Mar 25, 2023. (Total: 58925 Documents since 2012)
   dataset      
Filtered By:

Previous    

Records 1 - 30 (of 42 Records)

Next

Query Trace: Bladder Cancer[original query]>>Reviews/Commentaries[Product Type]
A Favorable Benefit-Risk Balance Maybe Expected with the Replication-defective Adenovirus-mediated Interferon Gene Therapy for Cancer Treatment.
Albert Qin et al. Human gene therapy 2023
Bladder Cancer Radiation Oncology of the Future: Prognostic Modelling, Radiomics, and Treatment Planning With Artificial Intelligence.
Moore Nicholas S et al. Seminars in radiation oncology 2022 33(1) 70-75
Genitourinary manifestations of Lynch syndrome in the urological practice.
Lonati Chiara et al. Asian journal of urology 2022 9(4) 443-450
Prognostic Role of RNA Expression Molecular Biomarkers in Prostate and Bladder Cancers.
Ahmed Mohamed E et al. European urology focus 2022
Explainable artificial intelligence (XAI): closing the gap between image analysis and navigation in complex invasive diagnostic procedures.
O'Sullivan S et al. World journal of urology 2022
The use of artificial intelligence for the diagnosis of bladder cancer: a review and perspectives.
Chan Erica On-Ting et al. Current opinion in urology 2021
Biomarker approach harnessed in trials of personalized medicine for bladder cancer
N Dizman et al, Nature Medicine, May 3, 2021
Bladder cancer in the time of machine learning: Intelligent tools for diagnosis and management.
Gandi Carlo et al. Urologia 2021 Jan 391560320987169
Genetic Differences Between Bladder and Upper Urinary Tract Carcinoma: Implications for Therapy.
Sfakianos John P et al. European urology oncology 2020 Dec
Activating Telomerase TERT Promoter Mutations and Their Application for the Detection of Bladder Cancer.
Zvereva Maria et al. International journal of molecular sciences 2020 Aug 21(17)
Application Areas of Traditional Molecular Genetic Methods and NGS in relation to Hereditary Urological Cancer Diagnosis.
Mikhaylenko Dmitry S et al. Journal of oncology 2020 20207363102
A Systematic Review on Mutation Markers for Bladder Cancer Diagnosis in Urine.
Hentschel A E et al. BJU international 2020 Jun
Application of artificial neural networks for automated analysis of cystoscopic images: a review of the current status and future prospects.
Negassi Misgana et al. World journal of urology 2020 Jan
Study Progress of Radiomics With Machine Learning for Precision Medicine in Bladder Cancer Management.
Ge Lingling et al. Frontiers in oncology 2019 91296
Artificial intelligence and neural networks in urology: current clinical applications.
Checcucci Enrico et al. Minerva urologica e nefrologica = The Italian journal of urology and nephrology 2019 Dec
The utility of next generation sequencing in advanced urothelial carcinoma.
Tripathi Abhishek et al. European urology focus 2019 Nov
Biology of nonmuscle-invasive bladder cancer: pathology, genomic implications, and immunology.
Dyrskjøt Lars et al. Current opinion in urology 2018 28(6) 598-603
FDA Approvals Provide Advances for a Range of Cancer Types
K Honey, AACR Blogs, August 6, 2019
Advances in risk stratification of bladder cancer to guide personalized medicine.
Matulay Justin T et al. F1000Research 2018 7
Can Biomarkers Guide the Use of Neoadjuvant Chemotherapy in T2 Bladder Cancer?
Grossman H Barton et al. European urology oncology 2019 Jul
Emerging genomic biomarkers for improving kidney, prostate, and bladder cancer health disparities outcomes.
Mitchell Khadijah A et al. Urologic oncology 2019 Jun
Bladder cancer: Multi-omic profiling refines the molecular view.
Hurst Carolyn D et al. Nature reviews. Clinical oncology 2018 15(4) 203-204
Molecular markers in disease detection and follow-up of patients with non-muscle invasive bladder cancer.
Maas Moritz et al. Expert review of molecular diagnostics 2018 18(5) 443-455
Hope and challenge: Precision medicine in bladder cancer.
Su Hongwei et al. Cancer medicine 2019 Mar
Clinical and Genomic Considerations for Variant Histology in Bladder Cancer.
Matulay Justin T et al. Current oncology reports 2019 Feb 21(3) 23
Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer.
Meric-Bernstam Funda et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 Nov
Genomic classification and risk stratification of bladder cancer.
Fantini Damiano et al. World journal of urology 2018 Nov
Novel biomarkers in bladder cancer.
Cheng Michael L et al. Urologic oncology 2018 36(3) 115-119
Precision medicine and bladder cancer heterogeneity.
Ma Guofeng et al. Bulletin du cancer 2018 Sep
The Cancer Genome Atlas Project in Bladder Cancer.
Rodriguez-Vida Alejo et al. Cancer treatment and research 2018 175259-271
TOP